JACQUELINE MURPHY: Open Payments
NPI 1902360332 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,799 in 202 payments from 24 companies in 2025. Trend: 2023 $2,736 · 2024 $4,853 · 2025 $6,799
Food & beverage: $4,968Travel & lodging: $1,832
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 7 | $1,491 |
| Medtronic, Inc. | 15 | $1,303 |
| ABBVIE INC. | 30 | $595 |
| Abbott Laboratories | 5 | $565 |
| Novartis Pharmaceuticals Corporation | 20 | $340 |
| UCB, Inc. | 18 | $316 |
| Amneal Pharmaceuticals LLC | 14 | $245 |
| Biogen, Inc. | 10 | $228 |
| Teva Pharmaceuticals USA, Inc. | 15 | $183 |
| Lilly USA, LLC | 6 | $180 |
Products named: Vercise, PERCEPT PC BRAINSENSE, INFINITY, KESIMPTA, QULIPTA, CREXONT, TYSABRI, Briviact.
Industry payments across AZ — which companies pay providers there.
